About: Metallibure

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Metallibure (INN) (brand names Aimax, Suisynchron, Turisynchron; former developmental code names ICI-33828, AY-61122, NSC-69536), also known as methallibure (USAN, BAN) or methallibur (German), is a medication which was introduced in 1973 and has been used in veterinary medicine to synchronize estrus. It was withdrawn in the United States and Europe due to teratogenicity and has been replaced with altrenogest (Regumate, Matrix), a progestin.

Property Value
dbo:abstract
  • Metallibure (INN) (brand names Aimax, Suisynchron, Turisynchron; former developmental code names ICI-33828, AY-61122, NSC-69536), also known as methallibure (USAN, BAN) or methallibur (German), is a medication which was introduced in 1973 and has been used in veterinary medicine to synchronize estrus. It was withdrawn in the United States and Europe due to teratogenicity and has been replaced with altrenogest (Regumate, Matrix), a progestin. The precise mechanism of action of metallibure is unknown. It has been described as a "nonsteroidal antigonadotropin" and it appears to act directly on the pituitary gland and/or hypothalamus to suppress gonadotropin secretion. However, metallibure has also been reported to be an antiprogestogen and to act specifically via inhibition of the biosynthesis or secretion of progesterone. Metallibure has similar endocrinological effects in women. It is associated with several unpleasant side effects including appetite loss, nausea, occasional vomiting, lethargy, and drowsiness. Animal toxicity studies revealed that the medication induced the development of cataracts, and this resulted in the termination of its clinical development. (en)
dbo:alternativeName
  • Aimax, Suisynchron, Turisynchron (en)
dbo:casNumber
  • 926-93-2
dbo:class
dbo:fdaUniiCode
  • MBU5XJ97C4
dbo:pubchem
  • 3003791
dbo:thumbnail
dbo:wikiPageID
  • 52456621 (xsd:integer)
dbo:wikiPageLength
  • 4827 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 993227425 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 7 (xsd:integer)
dbp:casNumber
  • 926 (xsd:integer)
dbp:chemspiderid
  • 2274191 (xsd:integer)
dbp:class
dbp:h
  • 14 (xsd:integer)
dbp:iupacName
  • 1 (xsd:integer)
dbp:n
  • 4 (xsd:integer)
dbp:pubchem
  • 3003791 (xsd:integer)
dbp:s
  • 2 (xsd:integer)
dbp:smiles
  • CCNCNNCNC (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • CGFFKDRVHZIQHL-UHFFFAOYSA-N (en)
dbp:synonyms
  • Methallibure; Methallibur; ICI-33828; AY-61122; NSC-69536 (en)
dbp:tradename
  • Aimax, Suisynchron, Turisynchron (en)
dbp:unii
  • MBU5XJ97C4 (en)
dbp:width
  • 250 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Metallibure (INN) (brand names Aimax, Suisynchron, Turisynchron; former developmental code names ICI-33828, AY-61122, NSC-69536), also known as methallibure (USAN, BAN) or methallibur (German), is a medication which was introduced in 1973 and has been used in veterinary medicine to synchronize estrus. It was withdrawn in the United States and Europe due to teratogenicity and has been replaced with altrenogest (Regumate, Matrix), a progestin. (en)
rdfs:label
  • Metallibure (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License